The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema

Ophthalmology

Volumn 122, Issue 7, 2015, Pages 1402-1415

  Ishibashi, Tatsuro ^a   Li, Xiaoxin ^b   Koh, Adrian ^c   Lai, Timothy Y Y ^d   Lee, Fenq Lih ^e   Lee, Won Ki ^f   Ma, Zhizhong ^g   Ohji, Masahito ^h   Tan, Nikolle ^c,i   Cha, Sung Bok ^j   Shamsazar, Jila ^j   Yau, C Lillian ^j  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f The Catholic University of Korea   (South Korea)

^g PEKING UNIVERSITY THIRD HOSPITAL   (China)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ NATIONAL HEALTHCARE GROUP EYE INSTITUTE   (Singapore)

^j NOVARTIS PHARMA AG   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANGINA PECTORIS; ARTICLE; ASIAN; BACTERIAL CONJUNCTIVITIS; BEST CORRECTED VISUAL ACUITY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CENTRAL RETINAL SUBFIELD THICKNESS; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DEVICE SAFETY; DIABETIC MACULAR EDEMA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EYE PAIN; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LASER; LOW LEVEL LASER THERAPY; LUMBAR SPINAL STENOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINAL THICKNESS; RHINOPHARYNGITIS; RISK ASSESSMENT; VISUAL ACUITY; VISUAL IMPAIRMENT; AGED; ANTAGONISTS AND INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIAL; COMPLICATION; DIABETIC RETINOPATHY; DOUBLE BLIND PROCEDURE; ETHNOLOGY; INTRAVITREAL DRUG ADMINISTRATION; LASER COAGULATION; MACULAR EDEMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PROGNOSIS;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ASIAN CONTINENTAL ANCESTRY GROUP; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PROGNOSIS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84937729172     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.02.006     Document Type: Article

References (31)

1. R. Klein, B.E. Klein, and S.E. Moss Visual impairment in diabetes Ophthalmology 91 1984 1 9
2. S.E. Moss, R. Klein, and B.E. Klein The 14-year incidence of visual loss in a diabetic population Ophthalmology 105 1998 998 1003
3. R. Klein, B.E. Klein, S.E. Moss, and et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema Ophthalmology 91 1984 1464 1474
4. S.M. Hariprasad, W.F. Mieler, M. Grassi, and et al. Vision-related quality of life in patients with diabetic macular oedema Br J Ophthalmol 92 2008 89 92
5. F.L. Ferris III, and A. Patz Macular edema. A complication of diabetic retinopathy Surv Ophthalmol 28 Suppl 1984 452 461
6. N. Ferrara, L. Damico, N. Shams, and et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration Retina 26 2006 859 870
7. P. Massin, F. Bandello, J.G. Garweg, and et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study Diabetes Care 33 2010 2399 2405
8. P. Mitchell, F. Bandello, U. Schmidt-Erfurth, and et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 2011 615 625
9. U. Schmidt-Erfurth, G.E. Lang, F.G. Holz, and et al. The RESTORE Extension study: three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema Ophthalmology 121 2014 1045 1053
10. M.J. Elman, L.P. Aiello, R.W. Beck the Diabetic Retinopathy Clinical Research Network Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
11. M.J. Elman, N.M. Bressler, H. Qin the Diabetic Retinopathy Clinical Research Network Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 118 2011 609 614
12. M.J. Elman, H. Qin, L.P. Aiello the Diabetic Retinopathy Clinical Research Network Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results Ophthalmology 119 2012 2312 2318
13. G.D. Nguyen, S.M. Shah, J.S. Heier READ-2 Study Group Primary end point (6 months) results of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) study Ophthalmology 116 2009 2175 2181
14. Q.D. Nguyen, S.M. Shah, A.A. Khwaja, and et al. Two-year outcomes of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
15. Q.D. Nguyen, D.M. Brown, D.M. Marcus, and et al. Ranibizumab for Diabetic Macular Edema: results from 2 phase III randomized trials Ophthalmology 119 2012 789 801
16. T.Y. Wong, R. Klein, F.M. Islam, and et al. Diabetic Retinopathy in a multi-ethnic cohort in the United States Am J Ophthalmol 141 2006 446 455
17. X.W. Xie, L. Xu, J.B. Jonas, and et al. Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Bejing Eye Study Eur J Ophthalmol 19 2009 91 99
18. N. Wang, X. Xu, H. Zou, and et al. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China Ophthalmologica 222 2008 32 36
19. T.Y. Wong, N. Cheung, W.T. Tay, and et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study Ophthalmology 115 2008 1869 1875
20. E. Chen, M. Looman, M. Laouri, and et al. Burden of illness of diabetic macular edema: literature review Curr Med Res Opin 26 2010 1587 1597
21. J.C. Chan, V. Malik, W. Jai, and et al. Diabetes in Asia: epidemiology, risk factors and pathophysiology JAMA 301 2009 2129 2140
22. L.M. Aiello Perspectives on Diabetic Retinopathy Am J Ophthalmol 136 2003 122 135
23. Early Treatment Diabetic Retinopathy Study Research Group Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19 Arch Ophthalmol 113 1995 1144 1155
24. M. Lovestam-Adrian, and E. Agardh Photocoagulation of diabetic macular oedema-complications and visual outcome Acta Ophthalmol Scand 78 2000 667 671
25. Diabetic Retinopathy Clinical Research Network A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema Ophthalmology 115 2008 1447 1459
26. N. Bhagat, R.A. Grigorian, A. Tutela, and M.A. Zarbin Diabetic macular edema: pathogenesis and treatment Surv Ophthalmol 54 2009 1 32
27. B.N. Mercer, S. Morais, R.M. Cubbon, and M.T. Kearney Diabetes mellitus and the heart Int J Clin Pract 66 2012 640 647
28. B.S. Baliga, and J. Weinberger Diabetes and stroke: part one. Risk factors and pathophysiology Curr Cardiol Rep 8 2006 23 28
29. A.I. Hatzitolios, T.P. Didangelos, A.T. Zantidis, and et al. Diabetes mellitus and cerebrovascular disease: which are the actual data? J Diabetes Complications 23 2009 283 296
30. P.E. Stanga, S.R. Boyd, and A.M.P. Hamilton Ocular manifestations of diabetes mellitus Curr Opin Ophthalmol 10 1999 483 489
31. M.J. Elman, A. Ayala, N.M. Bressler, and et al. Diabetic Retinopathy Clinical Research Network. Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results Ophthalmology 122 2015 375 381